PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PEPG is expected to report earnings to rise 5.88% to -72 cents per share on June 12
Q1'25
Est.
$-0.72
Q4'24
Beat
by $0.13
Q3'24
Beat
by $0.21
Q2'24
Missed
by $0.15
Q1'24
Beat
by $0.13
The last earnings report on February 24 showed earnings per share of -68 cents, beating the estimate of -81 cents. With 145.83K shares outstanding, the current market capitalization sits at 40.87M.